Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04471415
Title Study to Investigate DRP-104 in Adults With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Dracen Pharmaceuticals, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ESP | DEU

Facility Status City State Zip Country Details
HonorHealth Scottsdale Arizona 85258 United States Details
UCLA Los Angeles California 90095 United States Details
AdventHealth Medical Group Kissimmee Florida 34747 United States Details
Florida Cancer Specialist Orlando Florida 32827 United States Details
Johns Hopkins Kimmel Institute Baltimore Maryland 21231 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
NYU Langone New York New York 10016 United States Details
Icahn School of Medicine at Mount Sinai New York New York 10029-6574 United States Details
University of North Carolina Chapel Hill North Carolina 27514 United States Details
Ohio State University Comprehensive Cancer Center Columbus Ohio 43210 United States Details
Sarah Cannon Research Institute Nashville Tennessee 37203 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
NEXT Oncology Fairfax Virginia 22031 United States Details
Centrum fur Integrieerte Onkologie Cologne 50924 Germany Details
University Cancer Center NCT Dresden 01307 Germany Details
University Hospital Frankfurt Frankfurt 60590 Germany Details
University Klinikum Wuerzburg Würzburg 97070 Germany Details
National Cancer Center Singapore Singapore 169610 Singapore Details
Hospital University Vall d'Hebron Barcelona 08035 Spain Details
University Hospital 12 de Octubre Madrid 28041 Spain Details
National Taiwan University Hospital Taipei 100 Taiwan Details
Taipei Veterans General Hospital Taipei 112 Taiwan Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field